Project Inform applauds the recent recommendation by Covered California staff to cap specialty prescription drug costs at $250 per drug per month for 2016 Covered California Silver, Gold and Platinum level plans. The recommendation will be made Thursday, May 21 at the Covered California Board meeting….Read More
Dear Friends — As we enter our 30th year of service to the community. I write to share with you the immense pride I have in the accomplishments of Project Inform. I also write to ask if you will make a gift in support of Project Inform’s lifesaving…Read More
The unchecked spread of hepatitis C infection threatens the public health and economic welfare of the State of California. There are an estimated 750,000 Californians living with the hepatitis C virus (HCV)[i], and most do not know it[ii]. Untreated HCV can cause, among other conditions, cirrhosis…Read More
Project Inform is on the steering committee for this effort to bring new HIV infections to zero, along with zero deaths and zero stigma. Watch this PBS video for more information.
The U.S. Food and Drug Administration (FDA) has issued a warning about a potentially fatal interaction between the hepatitis C drug sofosbuvir (brand name Sovaldi) and the antiarrhythmic drug amiodarone following the death of one patient and the placement of three others on a pacemaker to…Read More
A new type of drug, called a toll-like receptor 7 (TLR7) agonist, was able to activate HIV-infected CD4 cells from HIV-positive donors on antiretroviral therapy (ART), leading to the release and replication of virus, according to a presentation at the 2015 Conference on Retroviruses and Opportunistic…Read More
A large study presented at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle found that offering gift cards to people to reward them for getting into HIV care after testing positive or for getting their viral loads suppressed doesn’t work better than the…Read More